David R Epstein's Net Worth

$7.29 Million

Estimate Recalculated Jun 17, 2024 08:47PM EST

Who is David R Epstein?

David R Epstein has an estimated net worth of $7.29 Million. This is based on reported shares across multiple companies, which include INTERNATIONAL FLAVORS & FRAGRANCES INC, Rubius Therapeutics, Inc., Molecular Insight Pharmaceuticals, Inc., Senti Biosciences, Inc., Opy Acquisition Corp. I, Axcella Health Inc., Evelo Biosciences, Inc., and Seagen Inc..

SEC CIK

David R Epstein's CIK is 0001445826

Past Insider Trading and Trends

2020 was David R Epstein's most active year for acquiring shares with 29 total transactions. David R Epstein's most active month to acquire stocks was the month of April. 2021 was David R Epstein's most active year for disposing of shares, totalling 23 transactions. David R Epstein's most active month to dispose stocks was the month of November. 2020 saw David R Epstein paying a total of $557,942.11 for 427,329.533 shares, this is the most they've acquired in one year. In 2023 David R Epstein cashed out on 654,215 shares for a total of $6,019,369.20, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) Snapshot price: $82.565

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Nov 2
Form 4
0
0
May 6
Form 4
0
0
May 1
Form 4
0
0
Nov 1
Form 4
0
0
May 1 - May 2
Form 4
0
0
May 3
Form 4
0
0
May 2
Form 4
0
0
May 3
Form 4
0
0
May 2
Form 4
0
0
Feb 1
Form 4
0
0
Feb 1
Form 4
0
0
Nov 1
Form 4
0
0
May 2
Form 4
0
0
Feb 1
Form 3
0
0
No matching records found

Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.057

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 12
Form 4
+0.64%
30K
$1.44
$43,329.00
4.72M
Apr 21
Form 4
0
0
May 12
Form 4
-0.57%
-26.70K
$14.93
-$398,559.87
4.69M
Scheduled
Feb 11
Form 4
-2.05%
-98.74K
$14.88
-$1,468,788.29
4.72M
Scheduled
Feb 8 - Feb 10
Form 4
0
0
May 21
Form 4
+0.10%
5K
$3.76
$18,800.00
4.82M
Mar 17
Form 4
+0.21%
10K
$3.91
$39,100.00
4.81M
Mar 13
Form 4
0
0
May 23
Form 4
0
0
Jul 17
Form 3
0
0
No matching records found

Molecular Insight Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Sep 22
Form 3
0
0
No matching records found

Senti Biosciences, Inc. (SNTI) Snapshot price: $0.4589

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jul 13
Form 4
+1,048.35%
112.52K
123.25K
Jun 8
Form 3
0
0
No matching records found

Opy Acquisition Corp. I (OHAA) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found